To counter China, FDA chief wants to speed new drug trial process
为抗衡manbetx3.0 ，FDA局长欲加快新药临床试验流程

The FDA plans to reduce the amount of data required to start a new drug trial in the US, cutting out most parts that aren’t safety-related, FDA Commissioner Marty Makary told reporters on Wednesday.
美国食品药品监督管理局(FDA)计划减少在美国启动新药临床试验所需的数据量，剔除大多数与安全性无关的部分，FDA局长马蒂•马卡里(Marty Makary)周三对记者表示。